Kolexia
Hoang-Xuan Khe
Neurologie
Hôpital Pitie Salpetriere
Paris, France
378 Activités
6 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Tumeurs du cerveau Gliome Tumeurs du système nerveux central Glioblastome Récidive tumorale locale Lymphome B diffus à grandes cellules Lymphome malin non hodgkinien Oligodendrogliome

Industries

Biogen
2 collaboration(s)
Dernière en 2022
PROTHERICS MEDICINES DEVELOPMENT LTD
2 collaboration(s)
Dernière en 2022
B3TSI
2 collaboration(s)
Dernière en 2021
Schlesinger Group France
2 collaboration(s)
Dernière en 2022

Dernières activités

Analysis of cerebrospinal fluid for the diagnosis of CNS lymphoma: Comparison of the ESCCA/ISCCA protocol and real-world data of the CytHem/LOC French network.
Cytometry. Part B, Clinical cytometry   07 mars 2024
Interim FDG-PET improves treatment failure prediction in primary central nervous system Lymphoma: a LOC network prospective multicentric study.
Neuro-oncology   16 février 2024
A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK.
Health science reports   05 janvier 2024
Epileptic seizures in patients with primary central nervous system lymphoma: A systematic review.
Revue neurologique   01 décembre 2023
EXTH-59. IDENTIFICATION OF GROWTH HORMONE RECEPTOR AS A RELEVANT TARGET FOR PRECISION MEDICINE IN LOW-EGFR EXPRESSING GLIOBLASTOMA
Abstracts from the 2023 Society for Neuro-Oncology’s 28th Annual Scientific Meeting and Education Day   10 novembre 2023
EPCO-52. SUBTYPES AND SURVIVAL ANALYSIS OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA WITH RADIOMICS FEATURES
Abstracts from the 2023 Society for Neuro-Oncology’s 28th Annual Scientific Meeting and Education Day   10 novembre 2023
Highly Sensitive Interleukin Score for Intra-Ocular Lymphoma Diagnosis: Evidence from Analysis of 5-Year Real-Life of Use
65th ASH Annual Meeting Abstracts   02 novembre 2023
JS07.5.A PROGNOSTIC FACTORS ASSOCIATED WITH POOR OUTCOME IN ADULT PATIENTS WITH MEDULLOBLASTOMA
Abstracts from the 18th Meeting of the European Association of Neuro-Oncology   08 septembre 2023
P14.08.A PROGNOSTIC VALUE OF CSF IL-10 AT THE 2-MONTH ASSESSMENT AFTER THE START OF INDUCTION CHEMOTHERAPY IN PRIMARY CNS LYMPHOMAS. A LOC NETWORK STUDY
Abstracts from the 18th Meeting of the European Association of Neuro-Oncology   08 septembre 2023
JS03.6.A NEUROTOXICITY IN PATIENTS WITH CNS LYMPHOMAS TREATED WITH CAR T CELL THERAPY. A LOC NETWORK STUDY
Abstracts from the 18th Meeting of the European Association of Neuro-Oncology   08 septembre 2023